The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity.
Open accessAbstract
Loss of telomeric DNA during cell proliferation may play a role in ageing and cancer. Since telomeres permit complete replication of eukaryotic chromosomes and protect their ends from recombination, we have measured telomere length, telomerase activity and chromosome rearrangements in human cells before and after transformation with SV40 or Ad5. In all mortal populations, telomeres shortened by approximately 65 bp/generation during the lifespan of the cultures. When transformed cells reached crisis, the length of the telomeric TTAGGG repeats was only approximately 1.5 kbp and many dicentric chromosomes were observed. In immortal cells, telomere length and frequency of dicentric chromosomes stabilized after crisis. Telomerase activity was not detectable in control or extended lifespan populations but was present in immortal populations. These results suggest that chromosomes with short (TTAGGG)n tracts are recombinogenic, critically shortened telomeres may be incompatible with cell proliferation and stabilization of telomere length by telomerase may be required for immortalization.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In primary cells deficient for Rb and p53, continued cellular growth beyond the Hayflick limit results in severe telomere shortening, marked genetic instability, and massive cell death—a period referred to as crisis (Counter et al. 1992”
From p53 Deficiency Rescues the Adverse Effects of Telomere Loss and Cooperates with Telomere Dysfunction to Accelerate Carcinogenesis (1999) · cites this paper as Counter et al. 1992
In the citing paper
“However, as these human fibroblasts undergo additional cell divisions, telomere erosion continues and the loss of telomere capping function produces rampant chromosomal instability and widespread apoptosis, a cellular state termed crisis (27).”
From Telomeres and telomerase in cancer (2010) · cites this paper as [27]
In the citing paper
“Crisis serves as the second checkpoint in tumor suppression and is characterized by multiple chromosomal fusions36.”
From Telomere dysfunction and tumour suppression: the senescence connection (2008) · cites this paper as [36]
In the citing paper
“Telomere maintenance is essential to the replicative potential of malignant cells and the inhibition of telomerase can lead to telomere shortening and cessation of unrestrained proliferation.”
From A highly selective telomerase inhibitor limiting human cancer cell proliferation (2001) · cites this paper as Counter et al., 1992
In the citing paper
“Eventually, telomeres shorten to a critical length and lose their ability to protect the ends of chromosomal DNA (Counter et al., 1992;Blasco et al., 1997).”
From A highly selective telomerase inhibitor limiting human cancer cell proliferation (2001) · cites this paper as Counter et al., 1992
In the citing paper
“Telomere maintenance is essential to the replicative potential of malignant cells and the inhibition of telomerase can lead to telomere shortening and cessation of unrestrained proliferation.”
From A highly selective telomerase inhibitor limiting human cancer cell proliferation (2001) · cites this paper as Counter et al., 1992
In the citing paper
“In cancer cells, the reactivation of telomerase is thought to stabilize telomere length, thereby compensating for the cell division-related telomere erosion and providing unlimited proliferative capacity to malignant cells (Counter et al., 1992;Kim et al., 1994).”
From A highly selective telomerase inhibitor limiting human cancer cell proliferation (2001) · cites this paper as Counter et al., 1992
In the citing paper
“In most normal human cells, telomerase activity is low or not detectable, and telomeric DNA is progressively lost at a rate of 30±120 bp with each replication cycle (Harley et al., 1990;Hastie et al., 1990;Counter et al., 1992).”
From A highly selective telomerase inhibitor limiting human cancer cell proliferation (2001) · cites this paper as Counter et al., 1992
Citations
Cites
A new technique for the assay of infectivity of human adenovirus 5 DNA
Graham, F. L., & van der Eb, A. J. (1973) · Virology · doi:10.1016/0042-6822(73)90341-3 · Cited by 9,302
Telomeres shorten during ageing of human fibroblasts
Harley, C. B., Futcher, A. B., & Greider, C. W. (1990) · Nature · doi:10.1038/345458a0 · Cited by 5,750
Self-citationCharacteristics of a human cell line transformed by DNA from human adenovirus type 5
Graham, F. L., Russell, W. C., Smiley, J., & Nairn, R. (1977) · Journal of General Virology · doi:10.1099/0022-1317-36-1-59 · Cited by 4,793
Structure and function of telomeres
Blackburn, E. H. (1991) · Nature · doi:10.1038/350569a0 · Cited by 3,596
Identification of a specific telomere terminal transferase activity in tetrahymena extracts
Greider, C. W., & Blackburn, E. H. (1985) · Cell · doi:10.1016/0092-8674(85)90170-9 · Cited by 3,400
Self-citationSouthern, P. J., & Berg, P. R. (1982) · PubMed · Cited by 2,740
Moyzis, R. K., Buckingham, J. M., Cram, L. S., Dani, M. A. C., Deaven, L. L., Jones, M. D., Meyne, J., Ratliff, R. L., & Wu, J. R. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.18.6622 · Cited by 2,326
Olovnikov (1973) · doi:10.1016/0022-5193(73)90198-7 · Cited by 1,847
Telomere reduction in human colorectal carcinoma and with ageing
Hastie, N. D., Dempster, M., Dunlop, M. G., Thompson, A. M., Green, D. K., & Allshire, R. C. (1990) · Nature · doi:10.1038/346866a0 · Cited by 1,650
A telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis
Greider, C. W., & Blackburn, E. H. (1989) · Nature · doi:10.1038/337331a0 · Cited by 1,643
Self-citation
Cited by
Sorted by citations
Items 701–800 of 1,003
Coleman, P. R., Hahn, C. N., Grimshaw, M. J., Lü, Y., Li, X., Brautigan, P. J., Beck, K., Stocker, R., Vadas, M. A., & Gamble, J. R. (2010) · Blood · doi:10.1182/blood-2009-11-252700 · Cited by 61
“Hybridization and washing were carried out as described.(23) The gel was autoradiographed on Kodak XAR-5 X-ray film for 12-24 h at room temperature.”
MethodApplications of physiological bases of ageing to forensic sciences. Estimation of age-at-death
Zapico, S. C., & Ubelaker, D. H. V. (2013) · Ageing Research Reviews · doi:10.1016/j.arr.2013.02.002 · Cited by 61
Ko, E., Seo, H., & Jung, G. (2017) · Hepatology · doi:10.1002/hep.29604 · Cited by 60
“Telomere elongation through telomerase activation enables cells to proliferate immortally and to protect them from genetic instability, thereby allowing cells to progress from a premalignant state to a malignant state.((30,31)) Although other investigators have also reported that telomerase activation is involved in m…”
BackgroundKokhaei, P., Palma, M., Hansson, L., Österborg, A., Mellstedt, H., & Choudhury, A. (2007) · Experimental Hematology · doi:10.1016/j.exphem.2006.10.006 · Cited by 60
Solution structure of the DNA-binding domain of human telomeric protein, hTRF1
Nishikawa, T., Nagadoi, A., Yoshimura, S., Aimoto, S., & Nishimura, Y. (1998) · Structure · doi:10.1016/s0969-2126(98)00106-3 · Cited by 62
Savoysky, E. (1996) · Nucleic Acids Research · doi:10.1093/nar/24.6.1175 · Cited by 60
Evolutionary links between telomeres and transposable elements
Pardue, M. L., Danilevskaya, O. N., Traverse, K. L., & Lowenhaupt, K. (1997) · Contemporary issues in genetics and evolution · doi:10.1007/978-94-011-4898-6_7 · Cited by 60
Telomerase activation in cervical cancer.
Anderson, S., Shera, K. A., Ihle, J., Billman, L., Goff, B. A., Greer, B. E., Tamimi, H. K., McDougall, J. K., & Klingelhutz, A. J. (1997) · Europe PMC (PubMed Central) · Cited by 60
Telomerase extracurricular activities
Chang, S. S., & DePinho, R. A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.212514699 · Cited by 61
Human Is a Unique Species among Primates in Terms of Telomere Length
Kakuo, S., Asaoka, K., & Ide, T. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1385 · Cited by 62
Uehara, H., Nardone, G., Nazarenko, I. A., & Hohman, R. J. (1999) · BioTechniques · doi:10.2144/99263pf01 · Cited by 61
Uncapping and Deregulation of Telomeres Lead to Detrimental Cellular Consequences in Yeast
Smith, C. D., & Blackburn, E. H. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.145.2.203 · Cited by 60
“Cells lacking either the TER gene or telomerase activity experience progressive telomere shortening with each cell division (Lundblad and Szostak, 1989; Counter et al., 1992; Singer and Gottschling, 1994; McEachern and Blackburn, 1995; Bodnar et al., 1998) until telomeric DNA is reduced below a critical length, result…”
BackgroundTargeted Tumor Therapy Remixed—An Update on the Use of Small-Molecule Drugs in Combination Therapies
Gatzka, M. (2018) · Cancers · doi:10.3390/cancers10060155 · Cited by 57
“Immortalization of tumor cells usually requires the induction and activation of telomerase to maintain telomere length and integrity and to prevent DNA damage responses [54].”
BackgroundTelomere dynamics: the influence of folate and DNA methylation
Moores, C. J., Fenech, M. F., & O’Callaghan, N. J. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06101.x · Cited by 61
Immortalized gingival fibroblasts as a cytotoxicity test model for dental materials
Illeperuma, R. P., Park, Y. J., Kim, J. M., Bae, J. Y., Che, Z. M., Son, H. K., Han, M. R., Kim, K., & Kim, J. (2011) · Journal of Materials Science Materials in Medicine · doi:10.1007/s10856-011-4473-6 · Cited by 59
“The replicative senescence caused by progressive telomeric DNA shortening in somatic cells is counteracted by telomerase, a ribonucleic protein complex which regulates the addition of telomeric DNA repeats at each round of DNA replication [20, 21].”
The role of telomere trimming in normal telomere length dynamics
Pickett, H. A., & Reddel, R. R. (2012) · Cell Cycle · doi:10.4161/cc.19632 · Cited by 61
Establishment of an Immortalized Human Hepatic Stellate Cell Line to Develop Antifibrotic Therapies
Shibata, N., Watanabe, T., Okitsu, T., Sakaguchi, M., Takesue, M., Kunieda, T., Omoto, K., Yamamoto, S., Tanaka, N., & Kobayashi, N. (2003) · Cell Transplantation · doi:10.3727/000000003108747064 · Cited by 59
Telomerase activity and telomere length as prognostic factors of adult T-cell leukemia
Kubuki, Y., Suzuki, M., Sasaki, H., Toyama, T., Yamashita, K., Maeda, K., Ido, A., Matsuoka, H., Okayama, A., Nakanishi, T., et al. (2004) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190400018349 · Cited by 61
“Thus, telomerase reactivation is thought to be essential for the stabilization of TL in order to attain cellular immortality in human carcinogenesis [3, 21].”
BackgroundVaziri, H., & Benchimol, S. (1999) · Oncogene · doi:10.1038/sj.onc.1203016 · Cited by 59
“Overcoming crisis is associated with maintenance of telomere length and reactivation of telomerase (Counter et al., 1992).”
BackgroundASSOCIATION BETWEEN OUTCOME AND TELOMERE DNA CONTENT IN PROSTATE CANCER
DONALDSON, L., Fordyce, C., Gilliland, F. D., Smith, A. Y., Feddersen, R. M., Joste, N. E., Moyzis, R. K., & Griffith, J. K. (1999) · The Journal of Urology · doi:10.1016/s0022-5347(05)68239-0 · Cited by 60
In Vitro Expansion of Human Hepatocytes is Restricted by Telomere-Dependent Replicative Aging
Wege, H., Chui, M. S., Le, H. T., Strom, S. C., & Zern, M. Α. (2003) · Cell Transplantation · doi:10.3727/000000003771000138 · Cited by 59
Preclinical and clinical strategies for development of telomerase and telomere inhibitors
Sharma, S., Raymond, É., Soda, H., Sun, D., Hilsenbeck, S., Sharma, A., Izbicka, E., Windle, B. E., & Hoff, D. D. V. (1997) · Annals of Oncology · doi:10.1023/a:1008206420505 · Cited by 59
“Experimental studies with human cells have revealed that replicative potential of cultured fibroblasts is directly proportional to mean TRF length [39] and chromosomes with critically shortened telomeric tracts may be incompatible with cellular proliferation and may require telomerase [39, 40].”
BackgroundPhosphatidylinositol 3-kinase related kinases
Abraham, R. T. (1996) · Current Opinion in Immunology · doi:10.1016/s0952-7915(96)80132-4 · Cited by 58
Cleal, K., Jones, R. E., Grimstead, J. W., Hendrickson, E. A., & Baird, D. M. (2019) · Genome Research · doi:10.1101/gr.240705.118 · Cited by 59
“In cells that bypass such checkpoints, further losses can disrupt the telomere nucleoprotein complex, exposing the telomere repeat array to the DNA repair machinery and resulting in the formation of telomere fusions (Counter et al. 1992).”
BackgroundThe Jekyll and Hyde of Cellular Senescence in Cancer
Demirci, D., Dayanc, B., Mazi, F. A., & Şentürk, Ş. (2021) · Cells · doi:10.3390/cells10020208 · Cited by 62
Hashimoto, Y., Murakami, Y., Uemura, K., Hayashidani, Y., Sudo, T., Ohge, H., Fukuda, E., Shimamoto, F., Sueda, T., & Hiyama, E. (2007) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-007-0383-9 · Cited by 57
“Consecutive telomere shortening ultimately leads to excessive telomere erosion, loss of telomere capping function, and eventually genetic instability and cellular senescence when telomeres become critically short.(14) Consequently, epithelial cells with excessive telomere shortening are mostly eliminated by protective…”
BackgroundEvolutionary links between telomeres and transposable elements
Pardue, M. L., Danilevskaya, O. N., Traverse, K. L., & Lowenhaupt, K. (1997) · Genetica · doi:10.1023/a:1018352706024 · Cited by 59
“The best known example is seen in human chromosomes where telomerase is inactive in many cell types and telomeres tend to shorten with age, although telomerase is reactivated upon tumorogenesis (Hastie et al., 1990; Counter et al., 1992).”
BackgroundApplication of telomerase assay for the screening of cervical lesions.
Kyo, S., Takakura, M., Ishikawa, H., Sasagawa, T., Satake, S., Tateno, M., & Inoue, M. (1997) · PubMed · Cited by 58
A Brief History of the Mortality and Immortality of Cultured Cells.
Hayflick, L. (1998) · The Keio Journal of Medicine · doi:10.2302/kjm.47.174 · Cited by 62
Targeting human telomeric G-quadruplex DNA with oxazole-containing macrocyclic compounds
Pilch, D. S., Barbieri, C. M., Rzuczek, S. G., LaVoie, E. J., & Rice, J. E. (2008) · Biochimie · doi:10.1016/j.biochi.2008.03.011 · Cited by 59
“Inhibition of telomerase activity is associated with telomeric shortening and subsequent activation of DNA damage responses that include cell cycle arrest, senescence, and apoptosis [19–26].”
BackgroundTelomere length measurement by Q-FISH
Slijepčević, P. (2001) · Springer eBooks · doi:10.1007/978-94-010-0330-8_3 · Cited by 57
Measurement of Telomerase Activity in Dog Tumors
Yazawa, M., Okuda, M., Setoguchi, A., Nishimura, R., Sasaki, N., Hasegawa, A., WATARI, & Tsujimoto, H. (1999) · Journal of Veterinary Medical Science · doi:10.1292/jvms.61.1125 · Cited by 57
Ding, L., Li, L. L., Yang, H. J., Tao, Y. G., Ye, M., Shi, Y., Tang, M., Wei, Y., Li, X. L., Gong, J. P., et al. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2005.04.012 · Cited by 57
Antitumor effects of specific telomerase inhibitor GRN163 in human glioblastoma xenografts
Ozawa, T., Gryaznov, S. M., Hu, L. J., Pongracz, K., Santos, R. A., Bollen, A. W., Lamborn, K. R., & Deen, D. F. (2004) · Neuro-Oncology · doi:10.1215/s1152851704000055 · Cited by 56
“Thus, cancer cell DNA is continuously extended or maintained by telomerase to compensate for the loss of telomeric repeats (Counter et al., 1992), and as a result the cells become immortalized.”
BackgroundSenescence and epigenetic dysregulation in cancer
Neumeister, P., Albanese, C., Balent, B., Greally, J., & Pestell, R. G. (2002) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(02)00079-1 · Cited by 56
Human chondrocyte senescence and osteoarthritis
Martin, J. A., & Buckwalter, J. A. (2002) · Biorheology · doi:10.1177/0006355x2002039001002017 · Cited by 56
“This fundamental barrier to unbridled growth, termed the Hayflick limit, is common to somatic cells that lack telomerase, an enzyme responsible for replacing telomere sequences [4,9,17,24].”
Campbell, L. J., Fidler, C., Eagleton, H., Peniket, A., Kušec, R., Gal, S., Littlewood, T. J., Wainscoat, J. S., & Boultwood, J. (2006) · Leukemia · doi:10.1038/sj.leu.2404141 · Cited by 58
Lee, G. E., Yu, E. Y., Cho, C. H., Lee, J., Muller, M. T., & Chung, I. K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401843200 · Cited by 56
Fletcher, T. M., Cathers, B. E., Ravikumar, K. S., Mamiya, B. M., & Kerwin, S. M. (2001) · Bioorganic Chemistry · doi:10.1006/bioo.2000.1194 · Cited by 57
Immuno-histochemical detection of human telomerase reverse transcriptase in human liver tissues
Kawakami, Y., Kitamoto, M., Nakanishi, T., Yasui, W., 田原, 榮., Nakayama, J., Ishikawa, F., Tahara, H., Ide, T., & Kajiyama, G. (2000) · Oncogene · doi:10.1038/sj.onc.1203733 · Cited by 56
“…a reverse-transcriptive DNA polymerase that synthesizes telomere DNA to compensate for the loss of telomeric DNA that occurs at each cell division, plays a major role in maintaining telomere length and in inde®nite replicative life span (Blackburn, 1992; Counter et al., 1992; Harley et al., 1991).”
BackgroundTelomere function and regulation from mouse models to human ageing and disease
Jones-Weinert, C. W., Mainz, L., & Karlseder, J. (2024) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-024-00800-5 · Cited by 63
“Mutations generated during crisis may include those that promote tumorigenesis or activate a telomere-maintenance mechanism (TMM) and thus allow for further cell growth in vitro and in vivo 24,25 .”
Label-Free Detection of Telomerase Activity Using Guanine Electrochemical Oxidation Signal
Eskiocak, U., Ozkan‐Ariksoysal, D., Özsöz, M., & Öktem, H. A. (2007) · Analytical Chemistry · doi:10.1021/ac071014r · Cited by 55
Osteoarthritis and telomere shortening
Kuszel, Ł., Trzeciak, T., Richter, M., & Czarny‐Ratajczak, M. (2014) · Journal of Applied Genetics · doi:10.1007/s13353-014-0251-8 · Cited by 55
“After each replication cycle, they are shortened by 50–150 bp (Harley et al. 1990; Counter et al. 1992).”
BackgroundMethodTelomeric DNA in normal and leukemic blood cells.
Yamada, O., Oshimi, K., Motoji, T., & Mizoguchi, H. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117759 · Cited by 55
SAKABE, H., Yahata, N., Kimura, T., Zeng, Z., Minamiguchi, H., Kaneko, H., Mori, K., Ohyashiki, K., Ohyashiki, J. H., Toyama, K., et al. (1998) · Leukemia · doi:10.1038/sj.leu.2401001 · Cited by 55
Kim, J. H., Kim, J. H., Lee, G. E., Kim, S. W., & Chung, I. K. (2003) · Biochemical Journal · doi:10.1042/bj20030363 · Cited by 54
Correlation of telomerase activity with development and progression of adult T-cell leukemia
Uchida, N., Otsuka, T., Arima, F., Shigematsu, H., Fukuyama, T., Maeda, M., Sugio, Y., Itoh, Y., & Niho, Y. (1999) · Leukemia Research · doi:10.1016/s0145-2126(98)00170-2 · Cited by 57
“Expression of telomerase and ensuing stabilization of telomeres appears to be concomitant with the attainment of immortality in cancer cells [17,18].”
BackgroundSalhab, M., Jiang, W. G., Newbold, R. F., & Mokbel, K. (2007) · Breast Cancer Research and Treatment · doi:10.1007/s10549-007-9622-8 · Cited by 55
“Activation of telomerase may therefore, be a critical step in human cancer development [12–14], since telomerase activity is absent in most normal human somatic cells, including breast tissue, but is present in 70–95% of malignant tissues and most immortal human cell lines [8, 15–27].”
BackgroundLiao, C.-H., Hsiao, Y., Sheu, G., Chang, J. T., Wang, P.-H., Wu, M., Shieh, G.-J., Hsu, C., & Ko, J. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.07.025 · Cited by 56
A mathematical model of cellular apoptosis and senescence through the dynamics of telomere loss
Arkus, N. (2005) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2004.12.016 · Cited by 53
“…that contain sufficient levels of ARTICLE IN PRESS www.elsevier.com/locate/yjtbi 0022-5193/$ -see front matter r 2005 Published by Elsevier Ltd. doi:10.1016/j.jtbi.2004.12.016 telomerase, such as stem cells and germ cells, can generally maintain a constant telomere length (Counter et al., 1992).”
BackgroundInfluentialKotoula, V., Hytiroglou, P., Pyrpasopoulou, A., Saxena, R., Thung, S. N., & Papadimitriou, C. S. (2002) · Liver International · doi:10.1046/j.0106-9543.2001.01594.x · Cited by 55
Drummond, M. W., Lennard, A. L., Brümmendorf, T. H., & Holyoake, T. L. (2004) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190410001693542 · Cited by 54
“M1) and, ultimately, genetic instability if cells are driven to crisis (block M2) [3].”
BackgroundOzer, H. L. (1999) · Progress in molecular and subcellular biology · doi:10.1007/978-3-662-06227-2_6 · Cited by 54
Models of initiation of replicative senescence by loss of telomeric DNA
Allsopp, R. (1996) · Experimental Gerontology · doi:10.1016/0531-5565(95)02008-x · Cited by 54
Telomere dysfunction: multiple paths to the same end
Harrington, L. A., & Robinson, M. O. (2002) · Oncogene · doi:10.1038/sj.onc.1205084 · Cited by 54
“…was gleaned Oncogene (2002) 21, 592 ± 597 ã 2002 Nature Publishing Group All rights reserved 0950 ± 9232/02 $25.00 www.nature.com/onc *Correspondence: MO Robinson; E-mail: mrobinso@amgen.com from following the fate of SV40-transformed human embryonic kidney cells (Counter et al., 1992).”
BackgroundInfluentialKim, W. T., Hennick, K. M., Johnson, J. Z., Finnerty, B., Choo, S.-A. S., Short, S. B., Drubin, C. W., Forster, R. E., McMaster, M. L., & Hockemeyer, D. F. (2021) · The EMBO Journal · doi:10.15252/embj.2020107346 · Cited by 55
“Second, telomere erosion occurring prior to telomerase activation can cause cancer-promoting genomic instability (Harley et al, 1990; Allsopp et al, 1992; Counter et al, 1992; Kim et al, 1994; Allsopp & Harley, 1995; Bodnar et al, 1998; Artandi et al, 2000) (reviewed in ref.”
Chalak, M., Hesaraki, M., Mirbahari, S. N., Yeganeh, M., Abdi, S., Rajabi, S., & Hemmatzadeh, F. (2024) · Life · doi:10.3390/life14030417 · Cited by 63
“…in the telomerase enzyme, which had recently been discovered in the single-cell Life 2024 , 14 , 417 6 of 22 Several reports confirmed the decrease in average telomere length with cell division in fibroblasts [6,57,58] and with age in somatic blood and colon cells [59], but not in germ cells.”
BackgroundSubhawong, A. P., Heaphy, C. M., Argani, P., Konishi, Y., Kouprina, N., Nassar, H., VANG, R. S., & Meeker, A. K. (2009) · Modern Pathology · doi:10.1038/modpathol.2009.125 · Cited by 59
Aubert, G. (2014) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-397898-1.00004-9 · Cited by 57
Gene targeting in livestock: a preview
Clark, A., Burl, S., Denning, C. N., & Dickinson, P. (2000) · Transgenic Research · doi:10.1023/a:1008974616402 · Cited by 53
“When telomeres fall below a critical length, chromosome abnormalities occur more frequently and replicative senescence occurs (Allsopp et al., 1992; Counter et al., 1992).”
BackgroundSato, N., Maehara, N., Mizumoto, K., Nagai, E., Yasoshima, T., Hirata, K., & Tanaka, M. (2001) · Cancer · doi:10.1002/1097-0142(20010201)91:3 · Cited by 51
Alterations in the p16INK4a and p53 tumor suppressor genes of hTERT-immortalized human fibroblasts
Noble, J. R., Zhong, Z.-H., Neumann, A. A., Melki, J. R., Clark, S. J., & Reddel, R. R. (2004) · Oncogene · doi:10.1038/sj.onc.1207440 · Cited by 53
Wang, Z., Kyo, S., Maida, Y., Takakura, M., Tanaka, M., Yatabe, N., Kanaya, T., Nakamura, M., Koike, K., Hisamoto, K., et al. (2002) · Oncogene · doi:10.1038/sj.onc.1205463 · Cited by 53
“Telomerase is usually inactivated in most somatic tissues but is widely activated in cancer cells (Kim et al., 1994; Shay and Bacchetti, 1997) and its activation is thought to be an essential step for cellular immortalization and carcinogenesis (Counter et al., 1992).”
BackgroundFunctional evidence for a telomerase repressor gene on human chromosome 10p15.1
Nishimoto, A., Miura, N., Horikawa, I., Kugoh, H., Murakami, Y., Hirohashi, S., Kawasaki, H., Gazdar, A. F., Shay, J. W., Barrett, J. C., et al. (2001) · Oncogene · doi:10.1038/sj.onc.1204165 · Cited by 53
“Telomerase activity is detected in most human cancers and immortalized cells (Counter et al., 1992; de Lange, 1994; Kim et al., 1994).”
BackgroundTelomerase activity in benign and malignant thyroid diseases
Yashima, K., Vuitch, F., Gazdar, A. F., & Fahey, T. J. (1997) · Surgery · doi:10.1016/s0039-6060(97)90220-8 · Cited by 53
Sealey, D., Zheng, L., Taboski, M. A. S., Cruickshank, J., Ikura, M., & Harrington, L. A. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp1160 · Cited by 53
“Recombinant Trx-HIS6hTERT(1–200) was mixed with radiolabeled single-stranded DNA oligonucleotides containing three full telomeric repeats and subjected to native polyacrylamide gel electrophoresis.”
InfluentialCatalytically active human telomerase mutants with allele-specific biological properties
Kim, M. (2003) · Experimental Cell Research · doi:10.1016/s0014-4827(03)00217-9 · Cited by 51
Telomerase: Dr Jekyll or Mr Hyde?
Prescott, J. C., & Blackburn, E. H. (1999) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(99)80055-0 · Cited by 52
Toward a molecular understanding of human breast cancer: A hypothesis
Shay, J. W., Wright, W. E., & Werbin, H. (1993) · Breast Cancer Research and Treatment · doi:10.1007/bf00662404 · Cited by 51
“Since telomerase activity is not present in somatic cells but is present in immortal and tumorigenic cells [19], it is likely that the restoration/activation of telomerase activity is important in the immortalization of cells.”
BackgroundTelomeres, Telomerase and Chromosome Stability
Preston, R. J. (1997) · Radiation Research · doi:10.2307/3579618 · Cited by 53
Brousset, P., Saati, T. A., Chaouche, N., Zenou, R. C., Schlaifer, D., Chittal, S. M., & Delsol, G. (1997) · Blood · doi:10.1182/blood.v89.1.26 · Cited by 52
Lead Exposure Induces Telomere Instability in Human Cells
Pottier, G., Viau, M., Ricoul, M., Shim, G., Bellamy, M., Cuceu, C., Hempel, W. M., & Sabatier, L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067501 · Cited by 51
“A correlation between reduced telomere length and dicentric chromosome frequency has been demonstrated in human senescent fibroblasts [14].”
BackgroundCatastrophic Endgames: Emerging Mechanisms of Telomere-Driven Genomic Instability
Cleal, K., & Baird, D. M. (2020) · Trends in Genetics · doi:10.1016/j.tig.2020.02.001 · Cited by 54
“The loss of telomeres during this extended replicative period is accompanied by a progressive increase in the frequency of telomere fusion events [17, 18].”
BackgroundCui, W., Wylie, D., Aslam, S., Dinnyés, A., King, T., Wilmut, I., & Clark, A. J. (2003) · Biology of Reproduction · doi:10.1095/biolreprod.102.013250 · Cited by 51
TELOMERASE ACTIVATOR1 Induces Telomerase Activity and Potentiates Responses to Auxin in Arabidopsis
Ren, S., Johnston, J. S., Shippen, D. E., & McKnight, T. D. (2004) · The Plant Cell · doi:10.1105/tpc.104.025072 · Cited by 51
“A similar situation is seen in telomerasepositive immortalizedhumancells (Counter et al., 1992;Kimet al., 1994), where telomeres are not perceptibly extended.”
BackgroundBielack, S., Beron, G., & Winkler, K. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19970801)80:3 · Cited by 37
Telomerase activity in cervical cancer is quantitatively distinct from that in its precursor lesions
Kyo, S., Takakura, M., Tanaka, M., Kanaya, T., & Inoue, M. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980220)79:1 · Cited by 51
Niccoli, S., Abraham, S., Richard, C., & Zehbe, I. (2012) · Journal of Virology · doi:10.1128/jvi.01512-12 · Cited by 49
Senescence: an antiviral defense that is tumor suppressive?
Reddel, R. R. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp274 · Cited by 52
Telomeres and genomic evolution
Baird, D. M. (2018) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2016.0437 · Cited by 51
“components of the Tp53 and RB pathways, can continue to divide and undergo further telomere erosion [36].”
Mondello, C., Chiesa, M., Rebuzzini, P., Zongaro, S., Verri, A., Colombo, T., Giulotto, E., D’Incalci, M., Franceschi, C., & Nuzzo, F. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)01484-0 · Cited by 50
Henderson, Y. C., Breau, R. L., Liu, T.-J., & Clayman, G. L. (2000) · Head & Neck · doi:10.1002/1097-0347(200007)22:4 · Cited by 52
Rb and E2F-1 regulate telomerase activity in human cancer cells
Crowe, D. L., & Nguyen, D. C. (2001) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(00)00296-7 · Cited by 51
Zhang, A., Wang, J., Zheng, B., Fang, X., Ångström, T., Liu, C., Li, X., Erlandsson, F., Björkholm, M., Nordenskjörd, M., et al. (2004) · Oncogene · doi:10.1038/sj.onc.1207527 · Cited by 50
Harada, K., Kurisu, K., Tahara, H., Tahara, E., Ide, T., & 田原, 榮. (2000) · Journal of neurosurgery · doi:10.3171/jns.2000.93.4.0618 · Cited by 50
Telomere Length as a Tool to Monitor Satellite Cell Amplification for Cell-Mediated Gene Therapy
Decary, S., Mouly, V., & Butler-Browne, G. S. (1996) · Human Gene Therapy · doi:10.1089/hum.1996.7.11-1347 · Cited by 50
“It has been well established that the length of telomeric D NA decreases as human somatic cells divide (e.g., fibroblasts, blood lympho cytes, embryonic kidney cells, and endothelial ceUs) (Harley al, 1990; Hastie et al, 1990; Counter et al, 1992; Chang and Harley, 1995).”
Telomerase activity in the testis of infertile patients with selected causes
Fujisawa, M., Tanaka, H., Tatsumi, N., Okada, H., Arakawa, S., & Kamidono, S. (1998) · Human Reproduction · doi:10.1093/humrep/13.6.1476 · Cited by 50
“Sertoli cell-only testes without germ cells showed no telomerase activity.”
BackgroundJoo, O. H., Hande, M. P., Lansdorp, P. M., & Natarajan, A. T. (1998) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/s0027-5107(97)00321-7 · Cited by 50
Garbe, J. C., Wong, M. P., Wigington, D., Yaswen, P., & Stampfer, M. R. (1999) · Oncogene · doi:10.1038/sj.onc.1202523 · Cited by 50
“Since EL cell telomeres continue to shorten with passage (Counter et al., 1992, 1994), while the immortally transformed cell lines show telomerase activity and stabilized telomere length, it has been postulated that this mutation involves reactivation of telomerase activity.”
BackgroundReflections on Telomeres, Growth, Aging, and Essential Hypertension
Aviv, A., & Aviv, H. (1997) · Hypertension · doi:10.1161/01.hyp.29.5.1067 · Cited by 50
Telomerase activity and telomere length in thyroid neoplasia: biological and clinical implications
Matthews, P., Jones, C. J., Skinner, J. W., Haughton, M. F., Micco, C. D., & Wynford‐Thomas, D. (2001) · The Journal of Pathology · doi:10.1002/path.848 · Cited by 48
“Such tumours would conform to the classic model [41] in which, after an initial period of telomere erosion, telomerase activity is acquired (usually through expression of hTERT) in time to stabilize telomere length at a level above the critical threshold required for cell survival.”
BackgroundKong, L.-J., Meloni, A. R., & Nevins, J. R. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.02.016 · Cited by 48
Nonhistone targets of KAT2A and KAT2B implicated in cancer biology
Bondy‐Chorney, E., Denoncourt, A. M., Sai, Y., & Downey, M. (2018) · Biochemistry and Cell Biology · doi:10.1139/bcb-2017-0297 · Cited by 50
Huang, F., Chang, C., Wang, J., Chang, T., & Lin, J. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01997.x · Cited by 50
“In most normal human cells, telomerase activity is low or not detectable, and telomeric DNA is progressively lost at a rate of 30–120 bp with each replication cycle (Hastie et al., 1990; Counter et al., 1992).”
BackgroundInfluentialCell Senescence in Human Aging and Disease
Fossel, M. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb02078.x · Cited by 49
Parsch, D., Brassat, U., Brümmendorf, T. H., & Fellenberg, J. (2008) · Cancer Investigation · doi:10.1080/07357900802072905 · Cited by 49
Telomere Dysfunction in Nonalcoholic Fatty Liver Disease and Cryptogenic Cirrhosis
Laish, I., Mannasse-Green, B., Hadary, R., Biron‐Shental, T., Konikoff, F. M., Amiel, A., & Kitay‐Cohen, Y. (2016) · Cytogenetic and Genome Research · doi:10.1159/000454654 · Cited by 51
Oxidative Damage Generated by an Oxo-Metalloporphyrin onto the Human Telomeric Sequence
Vialas, C., Pratviel, G., & Meunier, B. (2000) · Biochemistry · doi:10.1021/bi000743x · Cited by 52
Pritchard, D. E., Ceryak, S. M., Ha, L., Fornsaglio, J. L., Hartman, S. K., O’Brien, T. J., & Patierno, S. R. (2001) · PubMed · Cited by 49
Changes of telomere lengths in human intracranial tumours
N�rnberg, P., Thiel, G., Weber, F., & Epplen, J. T. (1993) · Human Genetics · doi:10.1007/bf00222724 · Cited by 49
“However, immortal cells seem to escape from progressive telomere shortening by expression of telomerase activity (Harley 1991; Counter et al. 1992).”
Background
Metadata
- Authors
- Counter, C. M., Avilion, A. A., LeFeuvre, C. E., Stewart, N. G., Greider, C. W., Harley, C. B., & Bacchetti, S.
- Affiliations
- McMaster University (CA)
- Venue
- The EMBO Journal
- Published
- 1992-05-01
- Volume
- 11
- Issue
- 5
- Pages
- 1921-1929
- ISSN
- 0261-4189 (ISSN-L)
- 1460-2075
- PMC
- PMC556651
- OpenAlex
- W1543500873
- Cited by
- 2,096
- References
- 53
- Citations by year
- 2026: 10 · 2025: 21 · 2024: 25 · 2023: 25 · 2022: 27 · 2021: 35 · 2020: 29 · 2019: 28 · 2018: 39 · 2017: 42 · 2016: 48 · 2015: 53 · 2014: 51 · 2013: 65 · 2012: 55
- FWCI
- 23.80
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- The EMBO Journal (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Cold Spring Harbor Laboratory Institutional Repository (Cold Spring Harbor Laboratory) (acceptedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Chromosomal and Genetic Variations
- Keywords
- telomere shortening, telomerase, chromosomal instability, cell immortalization, telomere length, dicentric chromosomes, telomeric DNA, SV40 transformation, adenovirus type 5, cell transformation, telomere recombination, cell proliferation, aging, cancer
- MeSH terms
- Cell Transformation, Neoplastic, Cell Transformation, Viral, Chromosomes, Human, DNA, DNA Nucleotidylexotransferase, Humans, Karyotyping, Kidney, Transfection, Telomere, Cellular Senescence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review